Micro Labs Limited — Atorvastatin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Atorvastatin · $13.7M export value · DGFT Verified
Micro Labs Limited is the #11 Indian exporter of Atorvastatin with $13.7M in export value and 413 verified shipments. Micro Labs Limited holds a 1.3% market share in Atorvastatin exports across 22 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Atorvastatin Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Atorvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.1M | 83 | 19.6% |
| JORDAN | $1.8M | 39 | 17.3% |
| IRAQ | $1.2M | 26 | 11.6% |
| MADAGASCAR | $987.2K | 99 | 9.3% |
| BELGIUM | $618.9K | 35 | 5.8% |
| GERMANY | $618.3K | 35 | 5.8% |
| NIGERIA | $538.1K | 31 | 5.0% |
| KENYA | $510.9K | 39 | 4.8% |
| MAURITIUS | $441.9K | 28 | 4.1% |
| NETHERLANDS | $372.8K | 9 | 3.5% |
Micro Labs Limited exports Atorvastatin to 24 countries. The largest destination is FRANCE accounting for 19.6% of Micro Labs Limited's Atorvastatin shipments, followed by JORDAN (17.3%) and IRAQ (11.6%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Atorvastatin from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $2.5M | 54 |
| E.P.DIS | FRANCE | $1.2M | 50 |
| MICRO LABS GMBH | BELGIUM | $623.8K | 28 |
| AL KAWKAB SCIENTIFIC BUREAU | JORDAN | $550.0K | 11 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $523.9K | 30 |
| MICRO LABS GMBH.. | BELGIUM | $454.2K | 15 |
| E P DIS | FRANCE | $424.7K | 17 |
| E.P.DIS.,., | FRANCE | $341.5K | 13 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $336.4K | 20 |
| SOMAPHAR | MADAGASCAR | $284.2K | 19 |
Micro Labs Limited supplies Atorvastatin to 54 buyers globally. The largest buyer is AL-KAWKAB SCIENTIFIC BUREAU (JORDAN), followed by E.P.DIS (FRANCE) and MICRO LABS GMBH (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Atorvastatin Export Value and How Much Does Micro Labs Limited Contribute?
India exported $313.7M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. Micro Labs Limited contributes $13.7M to this total, accounting for 1.3% of India's Atorvastatin exports. Micro Labs Limited ships Atorvastatin to 24 countries through 54 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Atorvastatin Exports?
Micro Labs Limited's average Atorvastatin shipment value is $33.2K per consignment, based on 413 shipments totaling $13.7M. The largest destination is FRANCE (19.6% of Micro Labs Limited's Atorvastatin exports).
How Does Micro Labs Limited Compare to Other Indian Atorvastatin Exporters?
Micro Labs Limited ranks #11 among 477 Indian Atorvastatin exporters with a 1.3% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($83.7M), AUROBINDO PHARMA LTD ($33.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($32.8M). Micro Labs Limited processed 413 shipments to 22 destination countries.
What Atorvastatin Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AVAS 20 ( (Atorvastatin Tablets 20mg) ) | $260.3K | 10 |
| DIRECT COMPRESSION GRANULES ATORVASTATIN | $226.4K | 9 |
| AVAS 20 (ATORVASTATIN 20MG TABLETS) PACK(3X10`S) (QTY-102048.000)PCS | $150.0K | 3 |
| AVAS-40 (ATORVASTATIN TABLETS 40MG )PACK3X10`S,QTY 102349.000 FAC INV NO 712202784PCS | $150.0K | 3 |
| AVAS-40 (ATORVASTATIN 40 MG TABLETS) (3X10S) - TAX INVOICE NO: 712202971 DT: 3004.2024 | $150.0K | 3 |
| AVAS 20 (ATORVASTATIN TABLETS 20MG) (3X10S) - TAX INVOICE NO: 712202992 DT: 14.05.2024 | $150.0K | 3 |
| AVAS 40 (ATORVASTATIN TABLETS 40MG) (3X10s) - TAX INVOICE NO: 701208873 DT: 30.05.2024 | $150.0K | 3 |
| AVAS 20 MG ( (ATORVASTATIN 20MG TABLETS)) ( 3X10S ) ( QTY- 29545.000 )PCS | $147.7K | 3 |
| AVAS 20 (ATORVASTATIN TABLETS 20MG) (3X10s) - TAX INVOICE NO: 701208873 DT: 30.05.2024 | $143.1K | 3 |
| AVAS 40 (ATORVASTATIN 40MG TABLETS) PACK(3X10`S) (QTY-51157.000)PCS | $135.1K | 3 |
Micro Labs Limited exports 390 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AVAS 20 ( (Atorvastatin Tablets 20mg) ) with 10 shipments worth $260.3K.
How Does Micro Labs Limited Compare to Nearest Atorvastatin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | MEDREICH LIMITED | $14.6M | 291 | 6 | $50.0K |
| 5 | ALKEM LABORATORIES LIMITED | $13.8M | 277 | 5 | $50.0K |
| 11 | MICRO LABS LIMITED ★ | $13.7M | 413 | 22 | $33.2K |
| 6 | UMEDICA LABORATORIES PRIVATE LIMITED | $11.8M | 235 | 8 | $50.0K |
| 12 | BIOCON PHARMA LIMITED | $11.4M | 229 | 2 | $50.0K |
Micro Labs Limited ranks #11 among 477 Indian Atorvastatin exporters. Average shipment value of $33.2K compared to the market average of $657.7K. The closest competitors by value are MEDREICH LIMITED and ALKEM LABORATORIES LIMITED.
Which Indian Ports Ship Atorvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 2,042 | 13.6% |
| HYDERABAD ICD (INSNF6) | 1,131 | 7.5% |
| NHAVA SHEVA SEA (INNSA1) | 842 | 5.6% |
| SAHAR AIR | 839 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 779 | 5.2% |
| DELHI AIR | 613 | 4.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 581 | 3.9% |
| HYDERABAD AIR | 554 | 3.7% |
What Other Cardiovascular Products Does Micro Labs Limited Export?
Micro Labs Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Micro Labs Limited's Atorvastatin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Atorvastatin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 521 individual customs records matching Micro Labs Limited exporting Atorvastatin, covering 390 formulations to 24 countries via 54 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Atorvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Atorvastatin Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current shipment-level data, contact TransData Nexus.